India crosses historic milestone of 1 crore HPV vaccine doses administered in less than 9 months

Nov 21, 2026

New Delhi [India], November 21 : India has achieved a major milestone in its efforts to prevent cervical cancer, with more than 1 crore doses of the Human Papillomavirus (HPV) vaccine administered under the National HPV Vaccination Campaign in less than nine months of its launch. 
The achievement marks a significant step towards protecting adolescent girls against HPV infections that can cause cervical cancer and reflects the growing reach of preventive healthcare services across the country, a press release stated.
Union Health and Family Welfare Minister JP Nadda noted that the achievement came in less than nine months since the nationwide campaign was launched by Prime Minister Narendra Modi on February 28, 2026. 
In a post on X, Nadda congratulated Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh, and Bihar for achieving 100 per cent coverage, while noting that 12 states have surpassed the 80 per cent mark.
"In less than nine months since its launch by Hon’ble PM Shri @narendramodi Ji, the National HPV Vaccination Campaign has achieved this historic milestone in protecting India’s daughters against cervical cancer," he said.
He added, "Congratulations to Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar for achieving 100% coverage, with 12 States surpassing 80%."
https://x.com/JPNadda/status/2123997353854329291?s=20
Launched by Prime Minister Narendra Modi in February 2026, the nationwide campaign provides free, safe and voluntary single-dose HPV vaccination, with parental consent, to 14-year-old girls at Government health facilities. The initiative represents a major advancement in India's preventive healthcare approach, with a focus on safeguarding the health and well-being of future generations of women.
According to the release, the campaign has achieved nearly 87 per cent cumulative coverage against the identified annual target cohort of approximately 1.2 crore girls, based on the Registrar General of India (RGI) 2021 population estimates. Reaching the 1 crore-dose milestone within nine months underscores the scale and momentum of the initiative, supported by coordinated efforts of States and Union Territories, healthcare professionals, frontline workers, teachers, parents and local communities.
States and Union Territories have demonstrated sustained progress in expanding HPV vaccination coverage, with several achieving high levels of coverage of their respective identified target populations.
Six States, including Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar, have achieved 100% coverage of their identified target populations under the campaign.
Among other high-performing States, Assam has recorded 95.63 per cent coverage, followed by Telangana (95.28 per cent), Karnataka (93.16 per cent) and Uttarakhand (90.17 per cent).
Chhattisgarh (86.21 per cent) and Rajasthan (85.23 per cent) have crossed the 80 per cent coverage mark, while Kerala (77.02 per cent), Tamil Nadu (76.12 per cent), Odisha (74.90 per cent) and the Union Territory of Dadra and Nagar Haveli and Daman and Diu (72.99 per cent) have achieved more than 70 per cent coverage, the release stated.
In terms of absolute numbers, Uttar Pradesh leads the country with more than 29.33 lakh 14-year-old girls vaccinated, followed by Bihar with over 13.70 lakh and Gujarat with over 7.75 lakh girls vaccinated.
The progress across States with diverse geographical, demographic and socioeconomic conditions highlights the extensive reach of the campaign and the effectiveness of locally adapted implementation strategies.
The release said that the milestone reflects sustained coordination between the Union Ministry of Health and Family Welfare and State and Union Territory Governments, supported by district administrations, public health institutions and frontline healthcare teams.
States and Union Territories have adopted tailored approaches to expand access to vaccination across rural, urban, remote and geographically challenging areas. State-led initiatives in Bihar, Tamil Nadu and Sikkim have also been integrated with the national campaign to strengthen outreach and implementation.
The campaign has placed particular emphasis on community engagement, parental awareness and the dissemination of credible, science-based information about HPV vaccination.
Healthcare professionals, including paediatricians, gynaecologists and specialists from premier medical institutions such as AIIMS, have played an important role in building awareness and addressing concerns regarding vaccine safety and effectiveness.
School teachers, Accredited Social Health Activists (ASHAs), Auxiliary Nurse Midwives (ANMs) and other frontline healthcare workers have also worked closely with parents and communities to encourage informed participation and counter misinformation.
These collective efforts have helped strengthen public confidence and facilitate the acceptance of HPV vaccination across different sections of society, the release noted.
Digital health infrastructure has been an important enabler of the nationwide campaign, with the U-WIN platform supporting real-time monitoring, beneficiary tracking and digital vaccination records.
Programme managers are using the platform to monitor vaccination progress at the district level, identify coverage gaps and eligible girls yet to be vaccinated, and support more effective planning and resource allocation.
The platform also enables parents to book HPV vaccination slots for their daughters and download digital vaccination certificates, making the vaccination process more accessible, convenient and transparent.
The integration of digital monitoring with field-level implementation is helping States and Union Territories strengthen programme management and reach eligible beneficiaries more effectively.
Cervical cancer remains a significant public health concern and an important cause of cancer-related illness and mortality among women. Persistent infection with certain high-risk types of Human Papillomavirus is responsible for the vast majority of cervical cancer cases.
As per the release, HPV vaccination is among the most effective preventive interventions available to reduce the risk of HPV infections that can lead to cervical cancer.
The National HPV Vaccination Campaign is supported by extensive global scientific evidence on the safety and effectiveness of HPV vaccines. More than 800 million HPV vaccine doses have been administered worldwide, while nearly two decades of scientific research and real-world experience have demonstrated strong protection against vaccine-targeted HPV infections and associated precancerous conditions.
By providing vaccination to girls at the age of 14 years, the campaign seeks to offer protection well before potential exposure to HPV, thereby contributing to the long-term prevention of cervical cancer.
Ensuring the safety and well-being of every beneficiary remains a fundamental priority of the campaign.
All vaccination sessions are conducted at designated Government health facilities under the direct supervision of trained Medical Officers. Vaccination sites are linked to 24×7 healthcare centres to facilitate prompt assessment, monitoring and management of any rare Adverse Events Following Immunisation (AEFI).
The campaign follows established vaccination safety protocols, supported by trained healthcare personnel and appropriate medical arrangements.
The Ministry continues to emphasise transparent communication, scientific evidence and informed parental consent to sustain confidence in the vaccination programme.
With the 1 crore-dose milestone achieved, the Ministry of Health and Family Welfare remains focused on reaching the remaining eligible girls and further strengthening vaccination coverage across all States and Union Territories, the release said.
The Ministry will continue working closely with State Governments, district administrations, medical professionals, frontline healthcare workers, educational institutions and communities to address coverage gaps, strengthen awareness and ensure equitable access to HPV vaccination.
Parents and guardians of eligible 14-year-old girls are encouraged to visit their nearest designated Government health facility or access the U-WIN platform to obtain information and book vaccination slots.
The achievement of administering more than 1 crore HPV vaccine doses in less than nine months is not merely a numerical milestone. It represents a significant investment in the health of India's adolescent girls and the prevention of a potentially life-threatening disease.
The National HPV Vaccination Campaign, launched under the leadership of PM Modi, reflects India's growing emphasis on preventive healthcare and its commitment to protecting women from avoidable illness.
The release highlighted that every HPV vaccine dose administered today is a step towards a healthier future for India's daughters and a future in which fewer women suffer from cervical cancer.
The milestone reinforces the Government of India's commitment to making preventive healthcare accessible to every eligible girl and advancing the national goal of reducing the burden of cervical cancer.
Ensuring the safety and well-being of every beneficiary remains a fundamental priority of the campaign.
All vaccination sessions are conducted at designated Government health facilities under the direct supervision of trained Medical Officers. Vaccination sites are linked to 24×7 healthcare centres to facilitate prompt assessment, monitoring and management of any rare Adverse Events Following Immunisation (AEFI).
The campaign follows established vaccination safety protocols, supported by trained healthcare personnel and appropriate medical arrangements, the release said.
The Ministry continues to emphasise transparent communication, scientific evidence and informed parental consent to sustain confidence in the vaccination programme.

More News